QuickView for gw7647 (compound)

1. Adipocyte gene expression after treatment with GW7647 or Rosiglitazone
2. HepG2 hepatocellular carcinoma gene expression after treatment with PPARalpha agonist GW7647
3. Fetal liver burst-forming unit erythroids (BFU-E) treated with dexamethasone (DEX) ± GW7647

1. PPAR-α Agonist GW7647 Protects Against Oxidative Stress and Iron Deposit via GPx4 in a Transgenic Mo…
2. The role of synthetic ligand of PPARα in regulation of transcription of genes related to mitochondri…
3. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic a…
4. PPARα activation promotes liver progenitor cell-mediated liver regeneration by suppressing YAP signa…
5. Downregulation of CPT1A exerts a protective effect in dextran sulfate sodium-induced ulcerative coli…

There were no clinical trials for gw7647